Literature DB >> 28416359

Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Huaqiang Zhou1, Yuanzhe Zhang2, Yiyan Song2, Wulin Tan3, Zeting Qiu1, Si Li2, Qinchang Chen2, Shaowei Gao4.   

Abstract

BACKGROUND AND OBJECTIVES: Marital status's prognostic impact on pancreatic neuroendocrine tumors (PNET) has not been rigorously studied. We aimed to explore the relationship between marital status and outcomes of PNET.
METHODS: We retrospectively investigated 2060 PNET cases between 2004 and 2010 from Surveillance, Epidemiology, and End Results (SEER) database. Variables were compared by Chi2 test, t-test as appropriate. Kaplan-Meier methods and COX proportional hazard models were used to ascertain independent prognostic factors.
RESULTS: Married patients had better 5-year overall survival (OS) (53.37% vs. 42.27%, P<0.001) and 5-year pancreatic neuroendocrine tumor specific survival (PNSS) (67.76% vs. 59.82%, P=0.001) comparing with unmarried patients. Multivariate analysis revealed marital status is an independent prognostic factor, with married patients showing better OS (HR=0.74; 95% CI: 0.65-0.84; P<0.001) and PNSS (HR=0.78; 95% CI: 0.66-0.92; P=0.004). Subgroup analysis suggested marital status plays a more important role in the PNET patients with distant stage rather than regional or localized disease.
CONCLUSIONS: Marital status is an independent prognostic factor for survival in PNET patients. Poor prognosis in unmarried patients may be associated with a delayed diagnosis with advanced tumor stage, psychosocial and socioeconomic factors. Further studies are needed.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Marital status; Pancreatic neuroendocrine tumors; Prognosis; SEER; Survival analysis

Mesh:

Year:  2017        PMID: 28416359     DOI: 10.1016/j.clinre.2017.02.008

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  30 in total

1.  Development and validation of prognostic nomograms for patients with metastatic prostate cancer.

Authors:  Wei-Dong Jiang; Ping-Cheng Yuan
Journal:  Int Urol Nephrol       Date:  2019-07-09       Impact factor: 2.370

Review 2.  Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2019-11-27       Impact factor: 4.512

3.  Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study.

Authors:  Nian Guo; Zhen Liang; Li Jiao Xiong
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  Survival Comparisons Between Early Male and Female Breast Cancer Patients.

Authors:  Kang Wang; Qiu-Juan Wang; Yong-Fu Xiong; Yang Shi; Wen-Jing Yang; Xiang Zhang; Hong-Yuan Li
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

5.  Prognostic factors of primary neuroendocrine breast cancer: A population-based study.

Authors:  Shu-Tao Ma; Ding-Yuan Wang; Yi-Bing Liu; Hui-Jing Tan; Yue-Yue Ge; Yihebali Chi; Bai-Lin Zhang
Journal:  Cancer Med       Date:  2022-05-02       Impact factor: 4.711

6.  Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases.

Authors:  Lianyuan Tao; Dianrong Xiu; Abuduhaibaier Sadula; Chen Ye; Qing Chen; Hanyan Wang; Zhipeng Zhang; Lingfu Zhang; Ming Tao; Chunhui Yuan
Journal:  Oncotarget       Date:  2017-07-24

7.  The Effect of Marital Status on Survival of Patients with Gastrointestinal Stromal Tumors: A SEER Database Analysis.

Authors:  Wei Song; Chuan Tian
Journal:  Gastroenterol Res Pract       Date:  2018-02-01       Impact factor: 2.260

8.  Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors.

Authors:  Dong-Liu Miao; Wei Song; Jun Qian; Zhi-Gang Zhu; Qiong Wu; Chang-Guang Lv; Lei Chen
Journal:  Transl Oncol       Date:  2018-07-14       Impact factor: 4.243

9.  Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study.

Authors:  Lianyuan Tao; Chunhui Yuan; Zhaolai Ma; Bin Jiang; Dianrong Xiu
Journal:  Cancer Manag Res       Date:  2017-10-03       Impact factor: 3.989

10.  Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.

Authors:  Huaqiang Zhou; Yuanzhe Zhang; Xiaoyue Wei; Kaibin Yang; Wulin Tan; Zeting Qiu; Si Li; Qinchang Chen; Yiyan Song; Shaowei Gao
Journal:  Cancer Med       Date:  2017-10-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.